IceCure Medical Statistics
Total Valuation
ICCM has a market cap or net worth of $35.78 million. The enterprise value is $25.36 million.
| Market Cap | 35.78M |
| Enterprise Value | 25.36M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ICCM has 47.94 million shares outstanding. The number of shares has increased by 2.44% in one year.
| Shares Outstanding | 47.94M |
| Shares Change (YoY) | +2.44% |
| Shares Change (QoQ) | +2.33% |
| Owned by Insiders (%) | 56.56% |
| Owned by Institutions (%) | 0.21% |
| Float | 21.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.97 |
| Forward PS | 8.87 |
| PB Ratio | 3.08 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.39 |
| Quick Ratio | 2.71 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 19.68 |
Financial Efficiency
Return on equity (ROE) is -101.70% and return on invested capital (ROIC) is -125.31%.
| Return on Equity (ROE) | -101.70% |
| Return on Assets (ROA) | -77.70% |
| Return on Capital (ROIC) | -125.31% |
| Revenue Per Employee | $42,364 |
| Profits Per Employee | -$188,221 |
| Employee Count | 77 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.28% in the last 52 weeks. The beta is 2.81, so ICCM's price volatility has been higher than the market average.
| Beta (5Y) | 2.81 |
| 52-Week Price Change | -37.28% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 39.53 |
| Average Volume (20 Days) | 128,435 |
Short Selling Information
The latest short interest is 154,875, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 154,875 |
| Short Previous Month | 164,273 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.73% |
| Short Ratio (days to cover) | 0.73 |
Income Statement
In the last 12 months, ICCM had revenue of $3.26 million and -$14.49 million in losses. Loss per share was -$0.32.
| Revenue | 3.26M |
| Gross Profit | 1.25M |
| Operating Income | -15.27M |
| Pretax Income | -14.49M |
| Net Income | -14.49M |
| EBITDA | -14.94M |
| EBIT | -15.27M |
| Loss Per Share | -$0.32 |
Balance Sheet
The company has $10.97 million in cash and $549,000 in debt, giving a net cash position of $10.42 million or $0.22 per share.
| Cash & Cash Equivalents | 10.97M |
| Total Debt | 549,000 |
| Net Cash | 10.42M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 11.64M |
| Book Value Per Share | 0.24 |
| Working Capital | 9.82M |
Cash Flow
In the last 12 months, operating cash flow was -$12.44 million and capital expenditures -$258,000, giving a free cash flow of -$12.69 million.
| Operating Cash Flow | -12.44M |
| Capital Expenditures | -258,000 |
| Free Cash Flow | -12.69M |
| FCF Per Share | -$0.27 |
Margins
Gross margin is 38.29%, with operating and profit margins of -468.09% and -444.30%.
| Gross Margin | 38.29% |
| Operating Margin | -468.09% |
| Pretax Margin | -444.30% |
| Profit Margin | -444.30% |
| EBITDA Margin | -458.00% |
| EBIT Margin | -468.09% |
| FCF Margin | -389.15% |
Dividends & Yields
ICCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.44% |
| Shareholder Yield | -2.44% |
| Earnings Yield | -40.50% |
| FCF Yield | -35.48% |
Analyst Forecast
The average price target for ICCM is $2.95, which is 295.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.95 |
| Price Target Difference | 295.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 94.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 10, 2021. It was a reverse split with a ratio of 1:8.
| Last Split Date | Aug 10, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
ICCM has an Altman Z-Score of -5.51 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.51 |
| Piotroski F-Score | 3 |